Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

4.20
Delayed Data
As of 3:58pm ET
 -0.17 / -3.89%
Today’s Change
3.47
Today|||52-Week Range
8.79
-11.58%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Aeglea Bio Therapeutics Inc have a median target of 13.50, with a high estimate of 22.00 and a low estimate of 5.00. The median estimate represents a +221.43% increase from the last price of 4.20.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Aeglea Bio Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$3.7M
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.13%
 
 
 
 
 
 
Growthannually 35.50%
 
 
 
 
 
 

Sales

Growthquarterly 161.60%
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.